The invention further comprises a pharmaceutical composition comprising {HEAD ~ an antibody} of the invention or {TAIL ~ an antigen binding fragment} thereof, a nucleic acid molecule of the invention, or an immunogenic polypeptide of the invention, and a pharmaceutically acceptable diluent or carrier 
of
The invention further comprises a pharmaceutical composition comprising { HEAD ~ an antibody } of the invention or { TAIL ~ an antigen binding fragment } thereof , a nucleic acid molecule of the invention , or an immunogenic polypeptide of the invention , and a pharmaceutically acceptable diluent or carrier
OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH